Prev Close | 137.02 |
Open | 137.09 |
Day Low/High | 135.90 / 137.41 |
52 Wk Low/High | 60.00 / 147.95 |
Volume | 2.14M |
Prev Close | 137.02 |
Open | 137.09 |
Day Low/High | 135.90 / 137.41 |
52 Wk Low/High | 60.00 / 147.95 |
Volume | 2.14M |
Exchange | NYSE |
Shares Outstanding | 1576.48B |
Market Cap | 217.00B |
P/E Ratio | 78.73 |
Div & Yield | N.A. (N.A) |
What would I do with the stocks? NKE is a terrific story, and TSLA's run into Battery Day has to be burned off, and it will.
Coming off Nike's strong report, Big 5 uses a strategy similar to TJX and even offers a dividend.
The pockets of strong movement are very narrow right now.
What We Need Now? Pure and simple. Follow through. Equity markets have to follow through.
The FATMAAN names are still bouncing but the sustainability of the rotations that have been taking place recently are in question.
If you have been riding the momentum in some good stocks, it's difficult to suddenly switch horses, but on days like Tuesday you might have to.
I would probably rather play this name from the short side, but the risk must be contained.
There is only one fact that truly needs to be understood. The virus is still in charge until it is not.
Upside price momentum has slowed.
The charts and indicators of the auto parts retailer are in pretty good shape, but market weakness could drag down its stock.
Let's give Doug some well wishes and that his bout of the flu is a mild one. Hopefully he gets some rest and recovery over the weekend. As we turn to the second half of today's trading, we have reports that Facebook is developing contingency plans ...
Unless there is something truly new at work, disregard the bump as nothing more than Wall Street silliness.
I will be long this name again. After the split. Before the iPhone 12.
The charts show a buy signal, and now is a good time to get into NKE.
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.
Markets may believe that we are closer to the effective use of vaccines and therapeutics than we know in this battle against Covid-19.
Investing isn't brain surgery: Keep a portfolio that's diversified with these qualities, and it will pay off on days like this.
The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.
Even the president has switched sides on this issue that could help flatten the curve and help get the economy rolling again.
Let's go over the confluence that allowed us to advance after a brief dip down in the morning.
Would I buy the name on this dip? Not yet. But here's what a trader could do.
Alright folks, thanks for letting play in the sandbox today and I hope I brought some value along with me. I'm off to get ready for the Nike earnings call. Once again I have to thank the editors who make this all look easy, while also making me look...
With about 90 minutes until today's trading comes to an end, leaving just three more days until we close out the June quarter, the major U.S. equity indices have been bouncing around and are currently modestly positive. Soon after the close, we'll ...
The immediate future remains under the control of virus-related statistics.
As Pimm Fox on Bloomberg Radio would say, good morning, good morning! With Doug out today, I'll be once again taking the Diary wheel for a spin. U.S. equities tumbled on Wednesday as the surge in reported coronavirus cases put the kybosh on the re-o...
There are stocks for people who believe we're roaring back, those who are hiding out from the virus, and those fearing gloom and doom. But here are the ones I'd give a workout.
I may go there, in small size, but just for a trade.
SWKS could pull back for a slightly better buying point, so traders should do some buying at current levels.
The Chinese economy is recovering and that's good news for Nike.
Other places besides the United States are flashing green, and they can surprise us -- even give our international companies a boost.